Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Kolin

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Cancers|November 30, 2018
Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous CarcinogenesisT Rinda Soong, David L Kolin, Nathan J Teschan, et al.
Biophysical Journal|June 1, 2005
Accuracy and dynamic range of spatial image correlation and cross-correlation spectroscopySantiago Costantino, Jonathan W D Comeau, David L Kolin, et al.
Gynecologic Oncology|March 21, 2025
Diagnostic and therapeutic advances for HER2-expressing or amplified gynecologic cancersElizabeth K Lee, David L Kolin, Ursula A Matulonis, et al.
Gynecologic Oncology Reports|July 14, 2023
Durable remission in a patient with <i>ERBB2</i>-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-PaclitaxelAlexander J Neil, Michael G Muto, David L Kolin, et al.
The American Journal of Surgical Pathology|November 30, 2018
A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the EndometriumDavid L Kolin, Danielle C Costigan, Fei Dong, et al.
Histopathology|March 31, 2025
Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinomaAlexander J Neil, Dingani Nkosi, Ju-Yoon Yoon, et al.
Histopathology|May 24, 2024
Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcomeNicolas Wyvekens, George L Mutter, Marisa R Nucci, et al.
The Journal of Chemical Physics|June 17, 2008
A guide to accurate measurement of diffusion using fluorescence correlation techniques with blinking quantum dot nanoparticle labelsAlexia I Bachir, David L Kolin, Katrin G Heinze, et al.
The American Journal of Surgical Pathology|December 9, 2024
Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type Endocervical Lesions and their Differential DiagnosesLawrence Hsu Lin, Harsimar Kaur, David L Kolin, et al.
The American Journal of Surgical Pathology|October 23, 2025
FGFR1 Mutations Are Rare Alternate Oncogenic Drivers in FOXL2-Wildtype Adult Granulosa Cell Tumors of the OvaryDavid L Kolin, Douglas A Mata, Douglas I Lin, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Cancers|November 30, 2018
Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous CarcinogenesisT Rinda Soong, David L Kolin, Nathan J Teschan, et al.
Biophysical Journal|June 1, 2005
Accuracy and dynamic range of spatial image correlation and cross-correlation spectroscopySantiago Costantino, Jonathan W D Comeau, David L Kolin, et al.
Gynecologic Oncology|March 21, 2025
Diagnostic and therapeutic advances for HER2-expressing or amplified gynecologic cancersElizabeth K Lee, David L Kolin, Ursula A Matulonis, et al.
Gynecologic Oncology Reports|July 14, 2023
Durable remission in a patient with <i>ERBB2</i>-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-PaclitaxelAlexander J Neil, Michael G Muto, David L Kolin, et al.
The American Journal of Surgical Pathology|November 30, 2018
A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the EndometriumDavid L Kolin, Danielle C Costigan, Fei Dong, et al.
Histopathology|March 31, 2025
Molecular and immunohistochemical characterization of ERBB2 activating mutations in low-grade serous ovarian carcinomaAlexander J Neil, Dingani Nkosi, Ju-Yoon Yoon, et al.
Histopathology|May 24, 2024
Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcomeNicolas Wyvekens, George L Mutter, Marisa R Nucci, et al.
The Journal of Chemical Physics|June 17, 2008
A guide to accurate measurement of diffusion using fluorescence correlation techniques with blinking quantum dot nanoparticle labelsAlexia I Bachir, David L Kolin, Katrin G Heinze, et al.
The American Journal of Surgical Pathology|December 9, 2024
Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type Endocervical Lesions and their Differential DiagnosesLawrence Hsu Lin, Harsimar Kaur, David L Kolin, et al.
The American Journal of Surgical Pathology|October 23, 2025
FGFR1 Mutations Are Rare Alternate Oncogenic Drivers in FOXL2-Wildtype Adult Granulosa Cell Tumors of the OvaryDavid L Kolin, Douglas A Mata, Douglas I Lin, et al.
Pageof 8